| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
POC Hgb A1C
Test CodePOCA1
Alias/See Also
A1C, Hemoglobin A1C, Glycosolated Hgb, Affinion Hemoglobin A1c, HbA1c
Preferred Specimen
1.5 μL of whole blood for analysis
- Capillary blood sample (from fingerstick)
- Venous whole blood collected with anticoagulants EDTA (LAV), heparin (GRN), or citrate (BLUE).
Minimum Volume
1.5 ul Whole blood
Specimen Stability
Capillary blood specimens cannot be stored.
Venous whole blood with anticoagulants (EDTA, heparin, or citrate) may be stored refrigerated for 10 days.
Venous whole blood with anticoagulants (EDTA, heparin, or citrate) may be stored refrigerated for 10 days.
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolyzed, Clotted
Methodology
Alere (Abbott) Afinion/Afinion 2
FDA Status
Waived
Setup Schedule
daily
Report Available
POC-result available immediately.
POC Results may be interfaced to the Patient Medical Record as an "unsolicited" result for many POC departments.
POC Results may be interfaced to the Patient Medical Record as an "unsolicited" result for many POC departments.
Limitations
Reportable Range HbA1c: 4%-15%
Note:
Note:
- If patient hemoglobin is < 6.0 or > 20 g/dL, use a different methodology for A1C testing.
- If patient HbA1c is <4% or >15%, use a different methodology for A1C testing.
Reference Range
Patient Reference Range HbA1c:: 4-6%
Clinical Significance
The Alere Afinion Hemoglobin A1c (HbA1c) is a waived in vitro diagnostic test for quantitative determination of glycated hemoglobin (% hemoglobin A1c, HbA1c) in human whole blood. The measurement of % HbA1c is recommended as a marker of long-term metabolic control in persons with diabetes mellitus. HbA1c values are reported according to the National Glycohemoglobin Standardization Program (NGSP) recommendations at Diabetes Control and Complications Trial (DCCT) level.
Performing Laboratory
CRMC POC Laboratory
